Professor of Biostatistics
Tel: (310) 825-2187
Fax: (310) 267-2113
Room: 51-253B CHS
Department of Biostatistics
650 Charles E. Young Drive South
Los Angeles, CA 90095-1772
B.S. Cooper Union (1975), Mathematics
M.S. University of Wisconsin (1977), Statistics
Ph.D. University of Wisconsin (1980), Statistics
Research & Interests
Dr. Brookmeyer, Professor of Biostatistics at the UCLA Fielding School of Public Health, conducts research at the interface of biostatistics and epidemiology. A main theme of his work concerns statistical and quantitative approaches for measuring the health of populations. He develops statistical methods and models for tracking and forecasting health and disease. He has worked extensively on the development of methods for tracking the course of the global HIV/AIDS epidemic. In other areas, Prof. Brookmeyer has pursued issues relating to bio-security having developed models for tracking and containing anthrax outbreaks. He has worked on global forecasts of Alzheimer’s disease and has ongoing projects in studies of aging populations. His research interests in biostatistical methodology include survival analysis, epidemic models, epidemiological methods and clinical trials.
Dr. Brookmeyer is an elected member of the Institute of Medicine of the National Academy of Sciences. He received the American Public Health Association’s Spiegelman Gold Medal for significant contributions to health statistics. He is a Fellow of the American Association for the Advancement of Science and of the American Statistical Association. Prior to his arrival at UCLA in 2010, Dr. Brookmeyer was Professor of Biostatistics and Director of the Master of Public Health Program at the Johns Hopkins University Bloomberg School of Public Health where he was the recipient of the University’s Stebbins Medal for contributions to educational programs. Dr. Brookmeyer was the 2011 Lester Breslow Distinguished Lecturer at UCLA and the 2012 Donna J Brogan Lecturer at Emory University.
Dr. Brookmeyer has served on numerous editorial boards and national scientific panels including the Committee on National Statistics of the National Research Council, the Institute of Medicine Panel on methodological challenges in HIV prevention trials, and the Institute of Medicine Panel to evaluate the President’s Emergency Fund for AIDS Relief (PEPFAR). He currently serves on the National Research Council’s Report Review Committee.